☆ 4.4 Article

Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report

CLINICAL LUNG CANCER (2019)

Get Full Text
Add to Collection

Journal

CLINICAL LUNG CANCER
Volume 20, Issue 4, Pages E514-E516

Publisher

CIG MEDIA GROUP, LP
DOI: 10.1016/j.cllc.2019.04.013

Keywords

Immunotherapy; MDSC; NSCLC; Predictive biomarkers; Tumor-induced immunosuppression

Categories

Oncology

Funding

  1. Italian Association for Cancer Research (AIRC) [18603, 12182]
  2. Cancer Research Institute (Clinic and Laboratory Integration Program, CLIP_2017)
  3. Cariverona Foundation
  4. MFAG_2018 AIRC [21509]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.